Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-17-002228
Filing Date
2017-08-28
Accepted
2017-08-28 16:55:38
Documents
3
Period of Report
2017-04-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 peregrine_10ka1-043017.htm 10-K/A 399287
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER peregrine_3101.htm EX-31.1 2804
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER peregrine_3102.htm EX-31.2 2983
  Complete submission text file 0001683168-17-002228.txt   406253
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

EIN.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K/A | Act: 34 | File No.: 001-32839 | Film No.: 171055120
SIC: 2834 Pharmaceutical Preparations